Buta–S

Información principal

  • Denominación comercial:
  • Buta–S Ibydi
  • Usar para:
  • Animales
  • Tipo de medicina:
  • medicamento alopático

Documentos

Localización

  • Disponible en:
  • Buta–S Ibydi
    Venezuela
  • Idioma:
  • español

Información terapéutica

  • indicaciones terapéuticas:
  • Inflamaciones severas, Infecciones agudas pulmonares, Miocarditis, Endocarditis, Mastitis , Artritis reumática, Traumática, Infecciosa y dolorosa. Desordenes musculoesqueléticos.
  • Resumen del producto:
  • Vía I.V.- I.M. Equinos y Bovinos adultos 30 ml. Potros y terneros 10 ml. Caprinos y Ovinos adultos y Porcinos 3.5 a 8 ml. Caprinos y Ovinos jóvenes y Caninso 0.5 a 4ml.

Otros datos

Estado

  • Fuente:
  • Instituto Nacional de Higiene - República Bolivariana de Venezuela
  • última actualización:
  • 03-09-2018

Prospecto

–S Ibydi

COMPOSICIÓN:Fenilbutazona 20%. Salicilato de sodio 2%.

INDICACIONES:Inflamaciones severas, Infecciones agudas pulmonares, Miocarditis, Endocarditis,

Mastitis, Artritis reumática, Traumática, Infecciosa y dolorosa. Desordenes musculoesqueléticos.

DOSIFICACIÓN:Vía I.V.- I.M. Equinos y Bovinos adultos 30 ml. Potros y terneros 10 ml. Caprinos y

Ovinos adultos y Porcinos 3.5 a 8 ml. Caprinos y Ovinos jóvenes y Caninso 0.5 a 4ml.

FABRICANTE:Ibydi

7-11-2018

Murray Wholesale Cash & Carry recalls King Universal Butane Fuel

Murray Wholesale Cash & Carry recalls King Universal Butane Fuel

The recalled products do not have proper hazard labelling as required by the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act.

Health Canada

5-11-2018

Vanpak Limited recalls David Ross Extra purified Butane gas

Vanpak Limited recalls David Ross Extra purified Butane gas

The recalled products do not have proper hazard labelling as required by the Consumer Chemicals and Containers Regulations, 2001 under the Canada Consumer Product Safety Act. Improper labelling could result in unintentional exposure to these products and lead to serious illness, injury or death.

Health Canada

29-8-2018

Review of the existing maximum residue levels for myclobutanil according to Article 12 of Regulation (EC) No 396/2005

Review of the existing maximum residue levels for myclobutanil according to Article 12 of Regulation (EC) No 396/2005

Published on: Mon, 13 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance myclobutanil. To assess the occurrence of myclobutanil residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, the MRLs established by the Codex Alimentarius Com...

Europe - EFSA - European Food Safety Authority Publications

28-6-2018

Ambient air quality: ANSES recommends the surveillance of 1,3-butadiene and the enhanced monitoring of ultrafine particles (UFPs) and carbon black

Ambient air quality: ANSES recommends the surveillance of 1,3-butadiene and the enhanced monitoring of ultrafine particles (UFPs) and carbon black

The European monitoring strategy for air quality relies heavily on quality standards for a number of pollutants. Advances in knowledge on the toxicity of substances and their emissions in the atmosphere have shown that certain pollutants that may have an impact on human health are not currently taken into account in regulatory monitoring. ANSES therefore received a formal request from the Ministries of Ecology and Health to propose a list of new priority pollutants for this air quality monitoring to supp...

France - Agence Nationale du Médicament Vétérinaire

28-8-2018

EU/3/18/2058 (IQVIA RDS Ireland Limited)

EU/3/18/2058 (IQVIA RDS Ireland Limited)

EU/3/18/2058 (Active substance: 1-(3-methylbutanoyl)-L-aspartyl-L-threonyl-L-histidyl-L-phenylalanyl-L-prolyl-(L-cystinyl-L-isoleucyl-[(N6-(S)-4-carboxy-4-palmitamidobutanoyl)-L-lysinyl]-L-phenylalanyl-L-glutamyl-L-prolyl-L-arginyl-L-serinyl-L-lysinyl-L-glycinyl-L-cystinyl)-L-lysinamide, disulfide, acetate) - Orphan designation - Commission Decision (2018)5730 of Tue, 28 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/099/18

Europe -DG Health and Food Safety